| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | +148.5% |
| R&D Expense | $23.3M | +16.8% |
| SG&A Expense | $12.6M | -5.4% |
| Operating Income | -$32.4M | -1.6% |
| Interest Expense | $2.3M | +27.6% |
| Income Tax | $0 | — |
| Net Income | -$22.7M | -243.5% |
| EPS (Basic) | -$0.55 | -152.4% |
| EPS (Diluted) | -$0.55 | -225.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.7M | -82.5% |
| Short-term Investments | $17.6M | — |
| Current Assets | $28.0M | -47.0% |
| Total Assets | $29.1M | -46.2% |
| Current Liabilities | $25.1M | +530.3% |
| Long-term Debt | $20.0M | +0.0% |
| Total Liabilities | $25.2M | -31.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.9M | -4.1% |
| Investing Cash Flow | -$17.9M | -3261.1% |
| Financing Cash Flow | $2.8M | -95.3% |
| Stockholders' Equity |
| $3.9M |
| -77.5% |